Public Health

GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

Global mental health continues to decline despite rising awareness

A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.

New 14-country study from Ipsos reveals self-blame, outdated narratives and a hidden daily toll.

New global syndicated survey highlights a striking contradiction at the heart of how obesity is understood, especially by those living with it.

Turn longevity from trend to strategy: where should pharma play - and how to win?

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Across 30 countries, 43% rate the quality of the healthcare they receive as good. For a third year running, mental health is seen as the biggest health issue, with 45% expressing concern. This is up from 27% in 2018. according to the Ipsos Healthcare Services Report 2025.

Read our new viewpoint and delve into the paradox of early cancer detection: how expanding screening methods – particularly multi-cancer early detection tests – while life-saving, pose considerations such as psychological impacts, false positives, and ethical dilemmas.